NDC 71285-0402

This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.

Requested NDC: 71285-0402
Product root: 71285-0402
Identity scope: Product
Primary current NDC product row: Not present

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
compounder	package	71285-0402	71285-0402-1	COMPOUNDER	Outsourcing facility compounded drug report	2020-1	2026-10-15
compounder	package	71285-0402	71285-0402-1	COMPOUNDER	Outsourcing facility compounded drug report	2019-2	2026-10-15
compounder	package	71285-0402	71285-0402-1	COMPOUNDER	Outsourcing facility compounded drug report	2019-1	2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 3 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Archive	Snapshot	Source SHA-256
2025-08-27 00:00 UTC · source 2025-08-20	compounder	package	71285-0402	71285-0402-1	COMPOUNDER	Outsourcing facility compounded drug report	2020-1	compounder / compounders_ndc_directory.zip	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	compounder	package	71285-0402	71285-0402-1	COMPOUNDER	Outsourcing facility compounded drug report	2019-2	compounder / compounders_ndc_directory.zip	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	compounder	package	71285-0402	71285-0402-1	COMPOUNDER	Outsourcing facility compounded drug report	2019-1	compounder / compounders_ndc_directory.zip	`af8e9b524e63…`	`ca326a94a5e9…`

Compounder NDC reports#

Browse the complete compounder directory for this NDC · Browse every current compounder row in the unified auxiliary catalog · browse compounder source captures and parsed snapshots.

Establishment, FEI, Product NDC table
Establishment	Product NDC	Package NDC	Product	Active ingredients	Reporting period	Normalization
"Central Admixture Pharmacy Services, Inc.(019684530)"	71285-0402	71285-0402-1	Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine	.3125 g/250 mL; .75 g/250 mL; .2375 g/250 mL; .0275 g/250 mL; .15 g/250 mL; .2625 g/250 mL; .015 g/250 mL; .3 g/250 mL; .75 g/250 mL; .01563 g/250 mL; 25 g/250 mL; .875 g/250 mL; .2125 g/250 mL; .425 g/250 mL; .2 g/250 mL; .5125 g/250 mL; .3375 g/250 mL; .225 g/250 mL; .3 g/250 mL; .125 g/250 mL; .4875 g/250 mL	2020-1	valid
"Central Admixture Pharmacy Services, Inc.(019684530)"	71285-0402	71285-0402-1	Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine	.3125 g/250 mL; .75 g/250 mL; .2375 g/250 mL; .0275 g/250 mL; .15 g/250 mL; .2625 g/250 mL; .015 g/250 mL; .3 g/250 mL; .75 g/250 mL; .01563 g/250 mL; 25 g/250 mL; .875 g/250 mL; .2125 g/250 mL; .425 g/250 mL; .2 g/250 mL; .5125 g/250 mL; .3375 g/250 mL; .225 g/250 mL; .3 g/250 mL; .125 g/250 mL; .4875 g/250 mL	2019-2	valid
"Central Admixture Pharmacy Services, Inc.(019684530)"	71285-0402	71285-0402-1	Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine	.3125 g/250 mL; .75 g/250 mL; .2375 g/250 mL; .0275 g/250 mL; .15 g/250 mL; .2625 g/250 mL; .015 g/250 mL; .3 g/250 mL; .75 g/250 mL; .01563 g/250 mL; 25 g/250 mL; .875 g/250 mL; .2125 g/250 mL; .425 g/250 mL; .2 g/250 mL; .5125 g/250 mL; .3375 g/250 mL; .225 g/250 mL; .3 g/250 mL; .125 g/250 mL; .4875 g/250 mL	2019-1	valid

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.